Sperimentazione in fase di reclutamento = ; Sperimentazione in corso = ; Sperimentazione conclusa = ; Finanziato da un ente associato a IRDiRC = ; Membro di una ERN =

Sperimentazioni cliniche nazionali

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

ALIFE2: Anticoagulants for living fetuses for women with recurrent miscarriage and inherited blood clotting disorders (phase 3) - AT

Institution: Information not provided - AT

Ulteriori dettagli

AUSTRIA

WIEN
WIEN

A Multicentre, Prospective, Open-label, Uncontrolled Phase 3 Study to Assess the Efficacy, Safety and Pharmacokinetics of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery - AT

Allgemeines Krankenhaus der Stadt Wien

Klinische Abteilung für Hämatologie und Hämostaseologie

Ulteriori dettagli

PAESI BASSI

Zuid-Holland
ROTTERDAM

COMPARE 60/80 HBR: Comparison of the Supraflex Cruz 60 Micron Stent Strut Versus the Ultimaster Tansei 80 Micron Stent Strut in High Bleeding Risk PCI Population

Maasstad Ziekenhuis

Polikliniek Cardiologie

Ulteriori dettagli